Author

Erik Rytting

Observed names: E. Rytting, Rytting, Erik

Institution: The University of Texas Medical Branch at Galveston

Observed institutions: Shenyang Pharmaceutical University, University of Copenhagen, Texas Biomedical Research Institute, National Institutes of Health, Children's Mercy Hospital, University of Kansas, Philipps University of Marburg, Bristol-Myers Squibb (United States), Eunice Kennedy Shriver National Institute of Child Health and Human Development, The University of Texas Medical Branch at Galveston, UConn Health

OpenAlex ID: A5091026624

Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development

2016 · John V. Ilekis, Ekaterini Tsilou, et al. · American Journal of Obstetrics and Gynecology · 293

Biodegradable polymeric nanocarriers for pulmonary drug delivery

2008 · Erik Rytting, Juliane Nguyen, et al. · Expert Opinion on Drug Delivery · 266

Preparation of nanoparticles by solvent displacement for drug delivery: A shift in the “ouzo region” upon drug loading

2010 · Moritz Beck-Broichsitter, Erik Rytting, et al. · European Journal of Pharmaceutical Sciences · 215

Placental transport and in vitro effects of Bisphenol A

2010 · Thit J. Mørck, Giuseppina Sorda, et al. · Reproductive Toxicology · 199

Modeling placental transport: Correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion

2009 · Marie Sønnegaard Poulsen, Erik Rytting, et al. · Toxicology in Vitro · 151

In vitro placental model optimization for nanoparticle transport studies

2012 · Erik Rytting, Cartwright, et al. · International Journal of Nanomedicine · 122

PDF

In Vitro Models for Studying Trophoblast Transcellular Transport

2006 · Claudia J. Bode, Hong Jin, et al. · Humana Press eBooks · 119

Aqueous and cosolvent solubility data for drug-like organic compounds

2005 · Erik Rytting, Kimberley A. Lentz, et al. · The AAPS Journal · 114

PDF

Placental control of drug delivery

2016 · Sanaalarab Al-Enazy, Shariq Ali, et al. · Advanced Drug Delivery Reviews · 112

Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model

2013 · Hazem Ali, Irina Kalashnikova, et al. · International Journal of Pharmaceutics · 102

Influence of Particle Size and Material Properties on Mucociliary Clearance from the Airways

2010 · Andreas Henning, Marc Schneider, et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 99

Charged nanoparticles as protein delivery systems: A feasibility study using lysozyme as model protein

2007 · Cuifang Cai, Udo Bakowsky, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 94

A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia

2021 · Maged M. Costantine, Holly West, et al. · American Journal of Obstetrics and Gynecology · 93

Kinetics of silica nanoparticles in the human placenta

2013 · Marie Sønnegaard Poulsen, Tina Mose, et al. · Nanotoxicology · 89

Pharmacokinetics of metoprolol during pregnancy and lactation

2015 · Rachel J. Ryu, Sara Eyal, et al. · The Journal of Clinical Pharmacology · 69

Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood–brain barrier and human placental trophoblast

2015 · Erik Rytting, Hazem Ali, et al. · International Journal of Nanomedicine · 64

PDF

Mucosal bromodomain-containing protein 4 mediates aeroallergen-induced inflammation and remodeling

2018 · Bing Tian, Koa Hosoki, et al. · Journal of Allergy and Clinical Immunology · 63

In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles

2009 · Erik Rytting, Michael Bur, et al. · Journal of Controlled Release · 61

Transport of Benzo[α]pyrene in the Dually Perfused Human Placenta Perfusion Model: Effect of Albumin in the Perfusion Medium

2009 · Line Mathiesen, Erik Rytting, et al. · Basic & Clinical Pharmacology & Toxicology · 61

Efficacy of Novel Highly Specific Bromodomain-Containing Protein 4 Inhibitors in Innate Inflammation–Driven Airway Remodeling

2018 · Bing Tian, Zhiqing Liu, et al. · American Journal of Respiratory Cell and Molecular Biology · 57

Selective Antagonists of the Bronchiolar Epithelial NF-κB-Bromodomain-Containing Protein 4 Pathway in Viral-Induced Airway Inflammation

2018 · Bing Tian, Zhiqing Liu, et al. · Cell Reports · 52

PDF

A Quantitative Structure-Property Relationship for Predicting Drug Solubility in PEG 400/Water Cosolvent Systems

2004 · Erik Rytting, Kimberley A. Lentz, et al. · Pharmaceutical Research · 48

Biodegradable Branched Polyesters Poly(vinyl sulfonate-covinyl alcohol)-graft Poly( d , l -lactic-coglycolic acid) as a Negatively Charged Polyelectrolyte Platform for Drug Delivery: Synthesis and Characterization

2008 · Xiaoying Wang, Xiulan Xie, et al. · Macromolecules · 44

Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA

2008 · Cuifang Cai, Shirui Mao, et al. · Journal of Microencapsulation · 42

Transport of digoxin-loaded Polymeric Nanoparticles Across BeWo cells, an In Vitro Model of Human Placental Trophoblast

2015 · Norah A Albekairi, Sanaalarab Al-Enazy, et al. · Therapeutic Delivery · 31

Works count: 93

Citation count: 3,120

H-index: 29

I10-index: 42